Spear Bio to Showcase Next-Generation Alzheimer’s Biomarker Technologies and Automated SPEAR Platform at AAIC 2026 Spear Bio, a biotechnology company specializing in ultrasensitive protein biomarker detection technologies, has announced that it will introduce several major additions to its biomarker research…
Bayer Forms Strategic Clinical Trials Alliance with University of Colorado Anschutz, UCHealth, and Children’s Hospital Colorado to Accelerate Medical Innovation Bayer has announced the formation of a landmark strategic alliance with the University of Colorado Anschutz Medical Campus (CU Anschutz),…
Ionis Pharmaceuticals Completes Enrollment in Pivotal Phase 3 REVEAL Study Cohort Evaluating Obudanersen for Angelman Syndrome Ionis Pharmaceuticals, Inc. has announced the completion of enrollment in the pivotal pediatric cohort of its global Phase 3 REVEAL clinical trial evaluating obudanersen…
Immunomic Therapeutics Doses First Participant in Phase 1 Trial of ITI-9001 Therapeutic Vaccine for Japanese Cedar Pollen Allergy Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and subsidiary of HLB, has announced the dosing of the first participant in its…
Visby Medical Receives FDA Clearance for First At-Home Multi-Viral PCR Test for COVID-19 and Influenza Visby Medical, a company focused on developing rapid molecular diagnostics for use at home, has announced that the U.S. Food and Drug Administration (FDA) has…
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Early Vessel Recoil in High-Risk CLTI Patients Reflow Medical, Inc. has announced the enrollment of the first participant in the DEEPER CHALLENGE clinical trial, marking an important milestone…
SC Therapeutics Launches REACH2 Clinical Trial to Evaluate Novel Disease-Modifying Therapy for Refractory Chronic Cough SC Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative therapies that target mechano-sensitive ion channels (MSCs) for the treatment of respiratory and cardiovascular diseases,…
CorVista Health Receives New AMA Category III CPT Code for AI-Powered Cardiovascular Diagnostic Technology CorVista Health has announced that the American Medical Association (AMA) has approved a new Category III Current Procedural Terminology (CPT®) code for its innovative artificial intelligence-powered…
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Candidate Fizurex™ Altasciences has announced the successful completion of a pivotal toxicology study for Steel Therapeutics Inc.’s lead investigational therapy, Fizurex™, marking an important step toward clinical development of a potential…
BRUKINSA Phase 3 Trial Shows Chemotherapy-Free Promise for Frontline Mantle Cell Lymphoma BeOne Medicines Ltd. has announced positive topline findings from its pivotal Phase 3 MANGROVE clinical trial, marking a significant milestone in the treatment of newly diagnosed mantle cell…
Biocytogen Secures Favorable Court Ruling in Patent Dispute, Reinforcing Confidence in Its RenNano® Technology Platform Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SSE: 688796; HKEX: 02315) has announced a significant legal victory following a first-instance civil judgment issued by the Shanghai Intellectual…
Genmab Reports Positive Phase 3 Results for Fixed-Duration Epcoritamab Combination in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Genmab A/S has announced positive topline results from its pivotal Phase 3 EPCORE DLBCL-4 clinical trial, demonstrating that a fixed-duration treatment regimen…